Table 3.
Duration of treatment | 1 g per day (0.25 g q.i.d) | 2 g per day (0.5 g q.i.d or 1 g b.i.d) | Totals |
---|---|---|---|
<14 days | NA | 5 of 11 subjects (45.5%) |
5 of 11 subjects (45.5%) |
≥14 days | 2 of 8 subjects (25%) |
0 of 44 subjects (0%)*† | 2 of 52 subjects (3.8%)* |
Totals | 2 of 8 subjects (25%) |
5 of 55 subjects (9.1%) | 7 of 63 subjects (11.1%) |
Significantly different from subjects treated <14 days (p < 0.001).
Significantly different from subjects treated with 1 g per day (p = 0.02).